It is a likely reason why the weight loss and liver fat numbers in trials look stronger than older single- or dual-pathway compounds
Most importantly, these metrics help redefine success
Preventative vs
CBO estimates that it would cost $1.5 billion to the federal government in the first year alone, rising to $6.1 billion in 2034 (see figure 1)
Los GLP-1 se recetan a adultos con un IMC (ndice de Masa Corporal) superior a 30, o a adultos con un IMC superior a 27 que tambin padecen afecciones relacionadas con la obesidad, como prediabetes, diabetes, hipertensin arterial, colesterol alto, apnea del sueo y enfermedad del hgado graso
Patients considering GLP-1 medications should consult their healthcare provider to discuss whether pharmaceutical intervention is appropriate for their specific clinical situation, including consideration of cardiovascular risk factors, degree of hyperglycemia, and previous response to lifestyle interventions